Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04697706 · ClinicalTrials.gov registry record · Early Phase 1
Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease
A Early Phase 1 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT04697706 is a Early Phase 1 study that has completed, run by NYU Langone Health. The registered enrollment target is 6 participants.
The verdict
NCT04697706, a Early Phase 1 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will investigate the effect of a patented high citrate beverage on urine chemistry in patients with urinary stone disease (USD). It is a minimal risk study of an over-the-counter beverage called Moonstone, which is commercially available. This study is considered preparatory for the RO-1 and is not intended to produce a definitive outcome regarding kidney stones.
Interventions
- OTHER Water
- DIETARY_SUPPLEMENT Moonstone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2020-12-14 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04697706
The ClinicalTrials.gov registry entry for NCT04697706 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT04697706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04697706 about?
NCT04697706 is a clinical study titled "Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease". This study will investigate the effect of a patented high citrate beverage on urine chemistry in patients with urinary stone disease (USD). It is a minimal risk study of an over-the-counter beverage called Moonstone, which is commercially available. This study is considered preparatory for the RO-1 ...
What is the current status of trial NCT04697706?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2020-09-01. Estimated completion is 2020-12-14.
What interventions are being tested in trial NCT04697706?
The interventions under investigation include: Water (OTHER), Moonstone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04697706?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.